Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial
Publication date: October 2026 Source: The Lancet Oncology, Volume 27, Issue 10 Author(s): Marloes J Hassing, Nicole E Billingy, Corina J G van den Hurk, Michel M van den Heuvel, Cornelia A Verberkt, Annemarie Becker-Commissaris, Iris Walraven, Hans J M Smit, Jeske A Staal van den Brekel, Frederieke Koppe, Judith Herder, Alle Welling, Olga C J Schuurbiers, Suzy M Samii, Wai Yee Lam-Wong, Wouter K de Jong, Katrien E A de Jaeger, Jos A Stigt, Nico C van Walree, Harm Jan Bogaard
Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial. // The Lancet Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S1470204526003050?dgcid=rss_sd_all
Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial. The Lancet Oncology. https://www.sciencedirect.com/science/article/pii/S1470204526003050?dgcid=rss_sd_all
“Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial.” The Lancet Oncology.
@article{article101622,
title = {Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial},
journal = {The Lancet Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S1470204526003050?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment